Company / Current Liabilities per Share
AbCellera Biologics Inc. Current Liabilities per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.22
FY2025
5-year range
$0.22 / $0.45
FY2021-FY2025
Trend
-17.5%
vs FY2024
Sector context
#188 of 210
Health Care
What the data says
Among 210 Health Care companies, AbCellera Biologics Inc. is in the top 10% for current liabilities per share. Current Liabilities per Share has declined for 4 consecutive years, from $0.45 in FY2021 to $0.22 in FY2025.
Based on SEC 10-K filings.
0.22 in FY2025 with a 5-year CAGR of -11.2%.
Improved from $0.41 to $0.22 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -19.6%
- 5-Year CAGR
- -11.2%
- 10-Year CAGR
- -
Sector benchmark
Top 10% in Health CareTop 10% of 210This company $0.22 Sector average $15.78
▼
-98.6% below sector average
Key checks
Key Insights
- AbCellera Biologics Inc.'s current liabilities per share has declined for 4 consecutive years.
- In FY2025, current liabilities per share decreased 17.5% year-over-year.
- Ranks #188 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.93 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.22 | -17.5% |
| FY2024 | $0.26 | -36.5% |
| FY2023 | $0.41 | -0.7% |
| FY2022 | $0.42 | -6.7% |
| FY2021 | $0.45 | +13.9% |
| FY2020 | $0.39 | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jul 1, 2026